Bullfrog AI (BFRG) Competitors $1.21 -0.02 (-1.63%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.22 +0.01 (+0.41%) As of 08/29/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRG vs. VTVT, LTRN, ANVS, JSPR, KLRS, BRNS, STTK, TELO, TPST, and KLTOShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include vTv Therapeutics (VTVT), Lantern Pharma (LTRN), Annovis Bio (ANVS), Jasper Therapeutics (JSPR), Kalaris Therapeutics (KLRS), Barinthus Biotherapeutics (BRNS), Shattuck Labs (STTK), Telomir Pharmaceuticals (TELO), Tempest Therapeutics (TPST), and Klotho Neurosciences (KLTO). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Its Competitors vTv Therapeutics Lantern Pharma Annovis Bio Jasper Therapeutics Kalaris Therapeutics Barinthus Biotherapeutics Shattuck Labs Telomir Pharmaceuticals Tempest Therapeutics Klotho Neurosciences Bullfrog AI (NASDAQ:BFRG) and vTv Therapeutics (NASDAQ:VTVT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk and dividends. Do analysts recommend BFRG or VTVT? vTv Therapeutics has a consensus price target of $35.50, suggesting a potential upside of 128.66%. Given vTv Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe vTv Therapeutics is more favorable than Bullfrog AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00vTv Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in BFRG or VTVT? 1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 17.5% of vTv Therapeutics shares are owned by institutional investors. 24.7% of Bullfrog AI shares are owned by insiders. Comparatively, 1.3% of vTv Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, BFRG or VTVT? Bullfrog AI has higher earnings, but lower revenue than vTv Therapeutics. vTv Therapeutics is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBullfrog AI$60K203.28-$6.99M-$0.76-1.59vTv Therapeutics$1.02M48.55-$18.46M-$3.12-4.98 Which has more volatility and risk, BFRG or VTVT? Bullfrog AI has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, vTv Therapeutics has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. Does the media prefer BFRG or VTVT? In the previous week, Bullfrog AI and Bullfrog AI both had 1 articles in the media. vTv Therapeutics' average media sentiment score of 1.88 beat Bullfrog AI's score of 0.93 indicating that vTv Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Bullfrog AI Positive vTv Therapeutics Very Positive Is BFRG or VTVT more profitable? vTv Therapeutics' return on equity of -179.75% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Bullfrog AIN/A -195.35% -162.37% vTv Therapeutics N/A -179.75%-55.91% SummaryvTv Therapeutics beats Bullfrog AI on 9 of the 14 factors compared between the two stocks. Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.20M$2.05B$5.69B$9.74BDividend YieldN/AN/A6.66%4.48%P/E Ratio-1.5938.0183.1926.59Price / Sales203.289.61515.50159.17Price / CashN/A52.0425.6628.92Price / Book2.1210.7911.716.08Net Income-$6.99M-$63.67M$3.27B$265.93M7 Day Performance-1.63%-0.71%1.13%0.36%1 Month Performance-6.92%10.44%8.30%5.58%1 Year Performance-53.10%30.31%62.26%19.67% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI0.7835 of 5 stars$1.21-1.6%N/A-53.1%$12.20M$60K-1.594VTVTvTv Therapeutics2.0172 of 5 stars$15.35-4.1%$35.50+131.3%-1.2%$48.95M$1.02M-4.929Gap DownLTRNLantern Pharma2.7725 of 5 stars$4.49-1.9%$25.00+457.4%-0.2%$48.49MN/A-2.5220ANVSAnnovis Bio1.9007 of 5 stars$2.46+9.8%$18.00+631.7%-72.6%$47.94MN/A-1.213Gap UpJSPRJasper Therapeutics3.2762 of 5 stars$2.94-0.7%$28.75+877.9%-87.2%$47.78MN/A-0.4920KLRSKalaris Therapeutics0.9551 of 5 stars$2.55+1.6%$3.00+17.6%N/A$47.69MN/A0.00110Positive NewsBRNSBarinthus Biotherapeutics2.8982 of 5 stars$1.17-2.1%$3.00+156.4%-14.5%$47.64M$14.97M-0.68107Positive NewsGap UpSTTKShattuck Labs3.4854 of 5 stars$0.99+0.0%$7.00+604.2%-72.7%$47.62M$3.00M-0.82100Gap DownTELOTelomir Pharmaceuticals2.4571 of 5 stars$1.47+0.7%$15.00+920.4%-74.8%$47.45MN/A-2.721Gap DownTPSTTempest Therapeutics1.9463 of 5 stars$10.58+0.1%$30.00+183.4%-40.8%$46.84MN/A-0.7220Positive NewsKLTOKlotho NeurosciencesN/A$0.76+0.5%N/AN/A$46.49MN/A-1.68N/A Related Companies and Tools Related Companies vTv Therapeutics Competitors Lantern Pharma Competitors Annovis Bio Competitors Jasper Therapeutics Competitors Kalaris Therapeutics Competitors Barinthus Biotherapeutics Competitors Shattuck Labs Competitors Telomir Pharmaceuticals Competitors Tempest Therapeutics Competitors Klotho Neurosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRG) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.